Literature DB >> 25422348

Overdose with antiepileptic drugs: the efficacy of extracorporeal removal techniques.

Rita Moinho1, Andrea Dias1, Paula Estanqueiro1, José Farela Neves1.   

Abstract

Drug overdose is a growing problem among adolescents. Clinical severity depends on the drug and ingested amount, which in some cases may be life-threatening. We present a clinical case of a previously healthy teenage girl who ingested 16.4 g of carbamazepine and 14.5 g of valproic acid. She presented with profound disturbance of consciousness and toxic levels of both drugs, raised in the first hours after the ingestion. She was successfully treated with charcoal haemoperfusion followed by continuous venovenous hemodiafiltration. Overdose with the two drugs separately is common, but there are no reports of intoxication by simultaneous ingestion. High levels of carbamazepine and valproic acid can lead to severe systemic effects and management is made difficult by the absence of specific antidotes. Extracorporeal removal techniques are a good therapeutic option in these cases as they enhance the clearance by reducing the half-life of both drugs thereby preventing serious complications. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25422348      PMCID: PMC4244515          DOI: 10.1136/bcr-2014-207761

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  25 in total

1.  Repeat charcoal hemoperfusion treatments in life threatening carbamazepine overdose.

Authors:  G Deshpande; K L Meert; R P Valentini
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

Review 2.  Adolescent suicide and suicidal behavior.

Authors:  Jeffrey A Bridge; Tina R Goldstein; David A Brent
Journal:  J Child Psychol Psychiatry       Date:  2006 Mar-Apr       Impact factor: 8.982

3.  Understanding the suicidal moment in adolescence.

Authors:  Regina Miranda; David Shaffer
Journal:  Ann N Y Acad Sci       Date:  2013-10-18       Impact factor: 5.691

4.  Continuous venovenous hemodiafiltration to treat controlled-release carbamazepine overdose in a pediatric patient.

Authors:  Tulay Sahin Yildiz; Demet Gedikbasi Toprak; Emin Sami Arisoy; Mine Solak; Kamil Toker
Journal:  Paediatr Anaesth       Date:  2006-11       Impact factor: 2.556

5.  Toxicology case of the month: Carbamazepine overdose.

Authors:  J Soderstrom; L Murray; M Little; F F S Daly
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

6.  Carbamazepine poisoning managed with haemodialysis and haemoperfusion in three adolescents.

Authors:  Kenan Bek; Sule Koçak; Ozan Ozkaya; Yunus Yilmaz; Omer Faruk Aydin; Cigdem Sag Taşdöven
Journal:  Nephrology (Carlton)       Date:  2007-02       Impact factor: 2.506

7.  Youth risk behavior surveillance - United States, 2011.

Authors:  Danice K Eaton; Laura Kann; Steve Kinchen; Shari Shanklin; Katherine H Flint; Joseph Hawkins; William A Harris; Richard Lowry; Tim McManus; David Chyen; Lisa Whittle; Connie Lim; Howell Wechsler
Journal:  MMWR Surveill Summ       Date:  2012-06-08

8.  Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow.

Authors:  Young K Chung; Kyung Y Chang; Hoon S Park; Mi-Hee Kim; Kang-Min Lee; Tae-Seok Lim; Hyung W Kim
Journal:  Hemodial Int       Date:  2014-01-15       Impact factor: 1.812

9.  Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis.

Authors:  David J Askenazi; Stuart L Goldstein; I-Fen Chang; Ewa Elenberg; Daniel I Feig
Journal:  Pediatrics       Date:  2004-02       Impact factor: 7.124

10.  Efficacy of charcoal hemoperfusion in massive carbamazepine poisoning.

Authors:  Robert J Cameron; P Hungerford; Andrew H Dawson
Journal:  J Toxicol Clin Toxicol       Date:  2002
View more
  1 in total

1.  Hemodiafiltration Treatment for Severe Valproic Acid Intoxication: Case Report and Updated Systematic Literature Review.

Authors:  Tobias Tichelbäcker; Judith Herath; Björn Tampe; Peter Korsten
Journal:  Front Med (Lausanne)       Date:  2018-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.